NEW FILINGS
Company: TELA Bio, Inc.
Symbol: TELA
Description: They are a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Jefferies, Piper Jaffray
Co-Manager: Canaccord Genuity, JMP Securities
Filed: 10-15-19
Listed Cash Raise: $69m
Company: Galera Therapeutics, Inc.
Symbol: GRTX
Description: They are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): BofA Merrill Lynch, Citigroup, Credit Suisse
Co-Manager: BTIG
Filed: 10-11-19
Listed Cash Raise: $86.25m
Company: 89bio, Inc.
Symbol: ETNB
Description: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): BofA Merrill Lynch, SVB Leerink, RBC Capital
Co-Manager: Oppenheimer
Filed: 10-11-19
Listed Cash Raise: $70m
Company: Centogene NV
Symbol: CNTG
Description: They are a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): SVB Leerink, Evercore ISI
Co-Manager: Baird, BTIG
Filed: 10-11-19
Listed Cash Raise: $69m
TERMS ADDED
Company: Progyny, Inc.
Symbol: PGNY
Description: They envision a world where anyone who wants to have a child can do so. Our mission is to make dreams of parenthood come true through healthy, timely and supported fertility journeys.
Shares: 10 million
Price Range: $14.00-$16.00
Market Cap: $1.15b-$1.3b
Trade Date: Friday, 10/25
Underwriter(s): J.P. Morgan, Goldman Sachs & Co, BofA Merrill Lynch, Citigroup
Co-Manager: Piper Jaffray, SVB Leerink, TPG Capital
Terms Added: 10-15-19
Company: Phathom Pharmaceuticals, Inc.
Symbol: PHAT
Description: They are a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases.
Shares: 7.9 million
Price Range: $18.00-$20.00
Market Cap: $465m-$520m
Trade Date: Friday, 10/25
Underwriter(s): Goldman Sachs, Jefferies, Evercore ISI
Co-Manager: Needham & Co.
Terms Added: 10-15-19
Company: OneWater Marine Inc.
Symbol: ONEW
Description: They are one of the largest and fastest-growing premium recreational boat retailers in the United States with 60 stores comprising 20 dealer groups in 11 states.
Shares: 3.157 million
Price Range: $14.00-$16.00
Market Cap: $171m-$190m
Trade Date: Thursday, 10/24
Underwriter(s): Goldman Sachs, Raymond James
Co-Manager(s): SunTrust Robinson Humphrey, B.Riley FBR
Terms Added: 10-15-19
Company: Youdao, Inc
Symbol: DAO
Description: For over a decade, Youdao has developed and used technologies to provide learning content, applications and solutions to users of all ages.
Shares: 5.6 million ADSs
Price Range: $15.00-$18.00
Market Cap: $342m-$410m
Trade Date: Friday, 10/25
Underwriter(s): Citigroup, Morgan Stanley, Credit Suisse, CICC, HSBC
Terms Added: 10-15-19
Company: Aesthetic Medical International Holdings Group Limited
Symbol: AIH
Description: They are a leading provider of aesthetic medical services in China.
Shares: 2.5 million ADSs
Price Range: $11.00-$13.00
Market Cap: $260m-$307m
Trade Date: Friday, 10/25
Underwriter(s): Cantor, Haitong International
Co-Manager: Prime Number Capital, Maxim Group, CMBI, Zinvest Global
Terms Added: 10-15-19
Company: Cabaletta Bio, Inc.
Symbol: CABA
Description: They are a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases.
Shares: 5.8 million
Price Range: $14.00-$16.00
Market Cap: $315m-$360m
Trade Date: Friday, 10/25
Underwriter(s): Morgan Stanley, Cowen, Evercore ISI
Terms Added: 10-16-19